|

|
Click to buy


Feature
4 pages
|
Looking for Ms. Right: Finding and Supporting Entrepreneurs in Nascent Entrepreneurial Environments
Thomas P. Dickerson and David L. Day
|
Abstract:
Of all the difficulties confronting locales attempting to develop their entrepreneurial environments, the most intractable is that of finding qualified entrepreneurs. A recognized, capable entrepreneur attracts both owners of the most promising technologies as well as investors. Such entrepreneurs are in short supply because the entrepreneurial task is so complex and so few people are capable of dealing with the variety of issues which entrepreneurs must face. The discussion which follows focuses on strategies that locales with developing entrepreneurial environments can undertake to ease these challenges.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Feature
(3 pages)
|
Patenting Personalized Medicine
Leena H. Karttunen, J. Amelia Feulner, David S. Resnick
|
Abstract:
This article discusses the patentable subject matter and timing of filing patent applications on the discoveries in the emerging field of personalized medicine.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Feature
(7 pages)
|
Modernization of our Healthcare Information System: Information Cooperativity
George Gaines, III and Kevin Pang
|
Abstract:
A number of legislative bills designed to speed the adoption of IT by providers through aid in capital investments necessary for the implementation of electronic health records or formation of regional health information are currently making their way through Congress. These bills do little to address several adoption hurdles; including the forward integration of patient health information resident on paper forms into electronic format, interoperability between different systems for effective information sharing, the creation of data capture, storage and transmission standards that allow relevant information to be accessed and presented, and the ability to scale while maintaining patient confidentiality and HIPAA regulation compliance. We examine some of the driving dynamics behind this recent legislative push, some important issues inhibiting adoption to consider, and the near and long term benefits of linking EHR systems to create the framework for a national health information network (NHIN).
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Feature
(9 pages)
|
The Legal Status of Embryos and Implications for Reproductive Technologies and Biotechnology Research
Krietta Kai Bowens
|
Abstract:
The legal status of embryos in American law is changing. At present, most states do not afford embryos the same protections as a born person, but some states are attempting to change this standard. Granting embryos the same legal status as born human beings poses a significant problem for industries that work with embryos, especially fertility treatment facilities and scientists researching stem cell and gene therapy technologies. This paper describes the methods of defining embryos in American law, and discusses the implications of granting embryos the same rights as born persons for the reproductive technology and scientific research industries.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Feature
(12 pages)
|
Financial Conflicts of Interest in Biomedical Human Subject Research
Nathan Goldstein
|
Abstract:
The purpose of this paper is to examine the past, present and future of financial conflict of interest regulation in biomedical human subject testing. Part I will briefly review the forces giving rise to the current controversy. Part II will examine the more influential ethical codes on human subject testing and argue that they are inconclusive on the subject of financial conflicts of interest. Part III will examine the various regulations now in place and identify their serious flaws. Part IV will critique the leading proposals for reform. The Conclusion will synthesize the best features of the various proposals for reform and suggest improvements left unaddressed by these proposals.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Feature
(6 pages)
|
The Øresund: In the Middle of Scandinavia, In the Middle of the Revolution
Lawrence B. Landman
|
Abstract:
Scandinavia's leading position in stem cell research is just the latest example of its long tradition of developing new medical technologies, and then turning these technologies into successful products. A recent report analyzed how entrepreneurial firms in the Copenhagen/Southern Sweden area are turning these technologies into tomorrow's products. The report concluded that firms in the area are to a surprising degree
trying to develop, not technologies to license, but products to sell. And these firms are doing so effectively.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Recent Developments: (2 pages)
|
The Bounds of Science and Ethics
Bryan A. Liang
|
Abstract:
No Abstract
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


Recent Developments:
(2 pages)
|
Obesity Remains a Global Problem
Laura A. Lin
|
Abstract:
Currently over one billion people are overweight globally, and if current trends continue, the World Health Organization (WHO) estimates 1.5 billion people will be overweight by 2015.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


|
FDA Approves New Blood Test to Improve Treatment for Colorectal Cancer
Danielle Gleason
|
Abstract:
The new blood test, Invader UGT1A1 Assay enables physicians to tailor dose of chemotherapeutic agents, which may be the beginning of "personalized medicine".
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


|
National Institutes of Health Enacts Final Ethics Regulations
April C. Ness
|
Abstract:
NIH new ethics regulations limit its employees activities, investments, and receipt of awards of NIH employees.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


|
Research Examines the Minimal Risk Standard for Pediatric Research
Arlene D. Luu
|
Abstract:
The "minimal" risk standard for protection of pediatric research subjects often fails due to unclear definitions and uneven IRB application, requiring an alternative standard to better assist pediatric research assessment.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


|
Face Transplants and the Difficulties of Obtaining Research Approval
Aline Gaba
|
Abstract:
After over one year of consideration, the world's first face transplant has obtained research approval despite ethical and safety concerns.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|
Click to buy


|
Stem Cell Research Debate Shifting to the Courts
Katherine R. Vick
|
Abstract:
California stem cell initiative faces legal challenges from groups opposing embryonic research and abortion opponents.
©2006
by The Journal of BioLaw & Business. All Rights Reserved.
Back
to Top
|